Fulltext

ANGI-12EFFICACY OF THE PENTRA®BODY DLX1008, A MONOVALENT ANTIBODY FRAGMENT WITH LOW PICOMOLAR AFFINITY TO VEGF-A, IN HUMAN GLIOMA MODELS IN VITRO AND IN VIVO

Szabo, Emese ; Phillips, Douglas ; Shamshiev, Japar ; Steinwand, Miriam ; Dreier, Nicole ; Howald, AnnaBianca ; Landi, Marco ; Marti, Andrea ; Winnewisser, Camilla ; Molitor, Julia ; Kretzschmar, Titus ; Weller, Michael

In: Neuro-Oncology, 2015, vol. 17, p. v43-v43

Aggiungi alla tua lista
    Titre
    • ANGI-12EFFICACY OF THE PENTRA®BODY DLX1008, A MONOVALENT ANTIBODY FRAGMENT WITH LOW PICOMOLAR AFFINITY TO VEGF-A, IN HUMAN GLIOMA MODELS IN VITRO AND IN VIVO
    Auteur
    • Szabo, Emese. Laboratory of Molecular Neuro-Oncology, Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland
    • Phillips, Douglas. Delenex Therapeutics AG, Schlieren, Switzerland
    • Shamshiev, Japar. Delenex Therapeutics AG, Schlieren, Switzerland
    • Steinwand, Miriam. Delenex Therapeutics AG, Schlieren, Switzerland
    • Dreier, Nicole. Delenex Therapeutics AG, Schlieren, Switzerland
    • Howald, AnnaBianca. Delenex Therapeutics AG, Schlieren, Switzerland
    • Landi, Marco. Delenex Therapeutics AG, Schlieren, Switzerland
    • Marti, Andrea. Delenex Therapeutics AG, Schlieren, Switzerland
    • Winnewisser, Camilla. Delenex Therapeutics AG, Schlieren, Switzerland
    • Molitor, Julia. Delenex Therapeutics AG, Schlieren, Switzerland
    • Kretzschmar, Titus. Delenex Therapeutics AG, Schlieren, Switzerland
    • Weller, Michael. Laboratory of Molecular Neuro-Oncology, Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland
    Type de document
    • Postprint
    Classification
    • Santé
    Identifiant OAI-PMH
    • oai:doc.rero.ch:292481